financetom
Business
financetom
/
Business
/
PyroGenesis Closed First Tranche of First Unit Group In Non-Brokered Private Placement for Near $3.5 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PyroGenesis Closed First Tranche of First Unit Group In Non-Brokered Private Placement for Near $3.5 Million
Oct 16, 2025 5:00 AM

07:17 AM EDT, 10/16/2025 (MT Newswires) -- PyroGenesis ( PYRGF ) , a player in innovating for ultra-high temperature processes and engineering, and a technology provider to heavy industry & defense, announced Thursday that it has completed the first tranche of the First Unit Group in previously announced non-brokered private placement by issuing and selling an aggregate of 5,555,556 units at a price of $0.63 per Unit, for gross proceeds of near $3.5 million.

A statement noted that P. Peter Pascali, the President and CEO of PyroGenesis ( PYRGF ), directly subscribed for the entire first tranche, representing an investment of approximately $3.5 million, through the acquisition of 5,555,556 Units at a price of $0.63 per Unit.

The first tranche of the Second Unit Group is expected to close next week. It involves the issuance and sale of 4 million units at a price of $0.20 per unit, for approximate gross proceeds of $800,000. Each warrant under this group entitles the holder to purchase one common share at a price of $0.40 for a period of 24 months following the closing date.

PyroGenesis ( PYRGF ) intends to use the proceeds of the Private Placement for working capital and general corporate purposes. It said the Private Placement has been conditionally approved by the TSX, but remains subject to the TSX's final approval, as well as other customary closing conditions.

Shares in PYR edged up in Canada trade yesterday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CeriBell Receives Authorization from Department of Veterans Affairs for EEG Technology
CeriBell Receives Authorization from Department of Veterans Affairs for EEG Technology
Nov 11, 2024
09:11 AM EST, 11/11/2024 (MT Newswires) -- CeriBell ( CBLL ) said Monday it received an authority to operate from the Department of Veterans Affairs, allowing the full deployment of the company's point-of-care electroencephalogram, or EEG, technology. The technology has been used in Veterans Administration in hospitals since 2018 but the new authorization allows wifi connection for remote access to...
Forum Energy Technologies Completes $100 Million Bond Issue
Forum Energy Technologies Completes $100 Million Bond Issue
Nov 11, 2024
09:08 AM EST, 11/11/2024 (MT Newswires) -- Forum Energy Technologies ( FET ) said Monday it completed a $100 million bond issuance with a 10.5% interest rate, maturing in 2029. The company said the net proceeds, combined with existing cash, were allocated to settle debt linked to the Variperm Energy Services acquisition and to redeem all outstanding 9% Convertible Senior...
Microsoft Azure's Expected H2 Acceleration Is Top of Mind for Investors, RBC Says
Microsoft Azure's Expected H2 Acceleration Is Top of Mind for Investors, RBC Says
Nov 11, 2024
09:13 AM EST, 11/11/2024 (MT Newswires) -- Microsoft ( MSFT ) Azure's expected acceleration in H2 has been the top of mind for investors in dialogues held by RBC Capital Markets since it met with some Microsoft ( MSFT ) executives recently, RBC said in a note Sunday. RBC said that overall, investors seemed disappointed with the company's fiscal Q1...
Ainos Receives Taiwan Hospital's Approval for Veldona Trial in Sjogren's Syndrome
Ainos Receives Taiwan Hospital's Approval for Veldona Trial in Sjogren's Syndrome
Nov 11, 2024
09:13 AM EST, 11/11/2024 (MT Newswires) -- Ainos (AIMD) said Monday it has received approval from the Institutional Review Board of Shuang Ho Hospital in Taiwan for the conduct of a clinical study of Veldona to treat Sjogren's syndrome. The company said it intends to submit to Taiwan's Food and Drug Administration by the end of this year and expects...
Copyright 2023-2026 - www.financetom.com All Rights Reserved